If patients are converted on Amiodarone of Cardizem IV they will be placed on

If patients are converted on amiodarone of cardizem

This preview shows page 7 - 11 out of 15 pages.

If patients are converted on Amiodarone of Cardizem IV, they will be placed on medication orally for maintenance. CONTINUED TREATMENT AND MANAGEMENT OF AF
Image of page 7
CONTINUED TREATMENT AND MANAGEMENT OF AF Anticoagulant medications reduces the risk of clot formation such as Aspirin 75 – 325 mg po everyday Coumadin 2-5 mg po everyday INR 2-3 initial dosage 10 mg po for 2 days Eliquis 5mg twice a day then decrease to 2.5 mg twice a day Pradaxa 150 mg twice a day Xarelto 20 mg daily
Image of page 8
CONTINUED TREATMENT AND MANAGEMENT OF AF The medication that will be focused on to treat AF will be Coumadin 10 mg daily for 2 days then it will be decrease after lab results (INR) Coumadin is subclass anticoagulants (Epocrates, 2018) Side effects Bleeding, ecchymosis, abdominal pain, nausea/vomiting, diarrhea Mechanism inhibits vitamin K dependent, coagulation factor synthesis (ll, Vll, lX, X, proteins C and S). Metabolized in the liver and excreted through urine Half-life 20-60 hours
Image of page 9
CONTINUED TREATMENT AND MANAGEMENT OF AF Diltiazem CD 120 mg daily Diltiazem CD subclass is antianginals, calcium channel blockers and non- dihydropyridine (Epocrates, 2018). Side effects peripheral edema, headaches, dizziness, asthenia, hypotension, orthostatic, bradycardia Mechanism it inhibits calcium ion influx into vascular smooth muscle & myocardium.
Image of page 10
Image of page 11

You've reached the end of your free preview.

Want to read all 15 pages?

  • Winter '16
  • Dr F
  • Atrial fibrillation, Diltiazem, ) RISK, AF Risk Factors

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture